Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) EBIT: 2015-2024

Historic EBIT for Evolus (EOLS) over the last 10 years, with Dec 2024 value amounting to -$34.4 million.

  • Evolus' EBIT rose 25.68% to -$11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.2 million, marking a year-over-year increase of 3.77%. This contributed to the annual value of -$34.4 million for FY2024, which is 30.11% up from last year.
  • Latest data reveals that Evolus reported EBIT of -$34.4 million as of FY2024, which was up 30.11% from -$49.2 million recorded in FY2023.
  • Evolus' EBIT's 5-year high stood at -$34.4 million during FY2024, with a 5-year trough of -$153.1 million in FY2020.
  • Over the past 3 years, Evolus' median EBIT value was -$49.2 million (recorded in 2023), while the average stood at -$49.7 million.
  • In the last 5 years, Evolus' EBIT plummeted by 54.70% in 2020 and then soared by 70.99% in 2021.
  • Yearly analysis of 5 years shows Evolus' EBIT stood at -$153.1 million in 2020, then surged by 70.99% to -$44.4 million in 2021, then tumbled by 47.12% to -$65.3 million in 2022, then increased by 24.64% to -$49.2 million in 2023, then spiked by 30.11% to -$34.4 million in 2024.